MedDataX Logo

MicroCutter in Surgical Stapling - European Trial I

NCT ID: NCT01476761

Last Updated: 2013-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate safety of the Microcutter stapling /cutting device in patients requiring the transection, resection or anastomosis of gastrointestinal tissue in a post-market approval study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective, open label, multi-center non-inferiority safety study with an all-comers enrollment of patients requiring surgical stapling of the stomach and/or intestine according to the labeled indications contained in the approved labeling. Up to 178 subjects consented for a 1-month clinical follow-up evaluation will be enrolled. Primary endpoint is to statistical non-inferiority of composite major adverse event rate (composite of infection (non-dermal), dehiscence, bleeding, and strictures) in study patients when compared to composite major adverse event rate (composite of infection (non-dermal), dehiscence, bleeding, and strictures) as derived from a comprehensive analysis of the medical literature. The comparison will be performed for cumulative events up to 30 days postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thoracic

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Surgical tissue resection Tissue dissection Tissue transection Anastomosis of gastrointestina tissue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MicroCutter Stapling Device

Patients undergoing surgical treatment with the MicroCutter Stapling Device

Group Type ACTIVE_COMPARATOR

Microcutter XPRESS and Microcutter XCHANGE

Intervention Type DEVICE

Surgical stapling devices

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Microcutter XPRESS and Microcutter XCHANGE

Surgical stapling devices

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MicroCutter XPRESS30 MicroCutter XPRESS45 MicroCutter XCHANGE30

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- All patients requiring surgical treatment where the use of a surgical stapler is anticipated

Exclusion Criteria

\- None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cardica, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andreas Kithe, M.D.

Role: PRINCIPAL_INVESTIGATOR

DRK-Krankenhaus Clementinenhaud, Hannover

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DRK-Krankenahus Clementinenhaus

Hanover, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Related Links

Access external resources that provide additional context or updates about the study.

http://www.cardica.com

Manufacturer of MicroCutter

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP 2011-01

Identifier Type: -

Identifier Source: org_study_id